Does Hepatitis B Immune Globulin Human Interact with Measles Vaccine?
CDI records a moderate classification for Hepatitis B Immune Globulin Human and Measles Vaccine. The stored summary is: Live virus vaccines should be deferred until approximately three months after administration of Hepatitis B Immune Globulin. Revaccination may be necessary if given shortly after live virus vaccination. The mechanism involves immune globulin may interfere with live vaccine effectiveness. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Hepatitis B Immune Globulin Human Class
- Human Immunoglobulin
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Immune globulin may interfere with live vaccine effectiveness
What To Tell Your Doctor or Pharmacist
If you are taking Hepatitis B Immune Globulin Human and your doctor is considering prescribing Measles Vaccine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider